Lack of Response to Vaccination in MGUS and Stable Myeloma

Trial Profile

Lack of Response to Vaccination in MGUS and Stable Myeloma

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Dec 2009

At a glance

  • Drugs Hepatitis B vaccine recombinant (Primary) ; Lenalidomide (Primary) ; Hepatitis B vaccine
  • Indications Hepatitis B
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Dec 2009 Interim results presented at the 51st Annual Meeting and Exposition of the American Society of Hematology.
    • 03 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top